These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18565387)

  • 21. Torsade de pointes induced by citalopram and amiodarone.
    Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V
    Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reply.
    Vieweg WV; Hasnain M; Howland RH
    Am J Med; 2013 Jun; 126(6):e23. PubMed ID: 23684406
    [No Abstract]   [Full Text] [Related]  

  • 23. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].
    Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
    Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095
    [No Abstract]   [Full Text] [Related]  

  • 24. QTc interval prolongation associated with citalopram overdose: a case report and literature review.
    Catalano G; Catalano MC; Epstein MA; Tsambiras PE
    Clin Neuropharmacol; 2001; 24(3):158-62. PubMed ID: 11391127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting.
    Crépeau-Gendron G; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Veinish S; Mah L
    J Affect Disord; 2019 May; 250():341-345. PubMed ID: 30877856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An electrocardiograph should be examined in patients with a hypersensitive esophagus before a trial of citalopram.
    Lee TH; Lee JS
    Am J Gastroenterol; 2013 May; 108(5):854. PubMed ID: 23644968
    [No Abstract]   [Full Text] [Related]  

  • 27. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
    Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unintended Consequences of Adjusting Citalopram Prescriptions Following the 2011 FDA Warning.
    Gerlach LB; Kales HC; Maust DT; Chiang C; Stano C; Choe HM; Zivin K
    Am J Geriatr Psychiatry; 2017 Apr; 25(4):407-414. PubMed ID: 28012712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citalopram and levosulpiride: a dangerous drug combination for QT prolongation.
    Agosti S; Casalino L; Bertero G; Burrone A; Brunelli C; Morelloni S
    Am J Emerg Med; 2013 Nov; 31(11):1624.e1-2. PubMed ID: 23896010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards limiting QT interval prolongation and arrhythmia risk in citalopram use.
    Zhang Y; Baranchuk A; Hancox JC
    Cardiol J; 2014; 21(5):454-7. PubMed ID: 25434987
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolonged QTc interval and torsades de pointes induced by citalopram.
    Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K
    Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.
    van Haelst IM; van Klei WA; Doodeman HJ; Warnier MJ; De Bruin ML; Kalkman CJ; Egberts TC
    J Clin Psychiatry; 2014 Jan; 75(1):15-21. PubMed ID: 24345304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe hypoglycaemia in citalopram overdose.
    Duncan RA; Armstrong PA; Paterson B
    Eur J Emerg Med; 2008 Aug; 15(4):234-5. PubMed ID: 19078823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In response to van Gorp F. et al. Escitalopram overdose.
    Lugassy DM; Hoffman RS; Chessex N
    Ann Emerg Med; 2010 Jan; 55(1):128-9; author reply 129-30. PubMed ID: 20116020
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the risk of QT prolongation among SSRIs.
    Funk KA; Bostwick JR
    Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nicorandil on QT prolongation and myocardial damage caused by citalopram in rats.
    Akturk G; Micili SC; Gursoy Doruk O; Hocaoglu N; Akan P; Ergur BU; Ahmed S; Kalkan S
    Biotech Histochem; 2023 Nov; 98(7):479-491. PubMed ID: 37466068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No Association Between Trazodone and Corrected-QT Prolongation in Older Adults.
    Armstrong SEM; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Crépeau-Gendron G; Mah L
    J Clin Psychopharmacol; 2019; 39(5):528-530. PubMed ID: 31433345
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs.
    Chastang A; Renet S; Corny J; Beaussier H; Petre A; Lillo-Lelouet A; Phan Thi TT; Bézie Y
    Int J Clin Pharm; 2019 Feb; 41(1):42-48. PubMed ID: 30610545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe transient neonatal long QT syndrome due to maternal paroxetine usage: a case report.
    Leerssen ECM; Tak RO; Breur JMPJ
    Cardiol Young; 2019 Oct; 29(10):1300-1301. PubMed ID: 31475669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.